1,804 results on '"Després, Jean-Pierre"'
Search Results
152. Lipoprotein lipase in aortic valve stenosis is associated with lipid retention and remodelling
153. DIABETES: Looking back at Look AHEAD—giving lifestyle a chance
154. LIPIDS IN 2012: HDL cholesterol studies —more of the same?
155. Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: individual participant meta-analysis
156. LIPIDS: HDL cholesterol is not HDL—donʼt judge the book by its cover
157. Amyloid substance within stenotic aortic valves promotes mineralization
158. Metabolic Syndrome Negatively Influences Disease Progression and Prognosis in Aortic Stenosis
159. Comprehensive Lipid Profiling Beyond LDL
160. Identifying which patients with diabetes should be tested for the presence of coronary artery disease – The importance of baseline electrocardiogram and exercise testing
161. Genotype of the mutant LDL receptor allele is associated with LDL particle size heterogeneity in familial hypercholesterolemia
162. Apolipoprotein-B, Low-Density Lipoprotein Cholesterol, and the Long-Term Risk of Coronary Heart Disease in Men
163. Endocannabinoid Receptor Blockers
164. Contributing Authors
165. Sleep apnoea attenuates the effects of a lifestyle intervention programme in men with visceral obesity
166. What Is “Metabolically Healthy Obesity”?: From Epidemiology to Pathophysiological Insights
167. Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Lowering With Atorvastatin in Patients of South Asian Compared With European Origin: Insights From the Achieve Cholesterol Targets Fast With Atorvastatin Stratified Titration (ACTFAST) Study
168. Visceral Adipose Tissue Indicates the Severity of Cardiometabolic Risk in Patients with and without Type 2 Diabetes: Results from the INSPIRE ME IAA Study
169. Elevated Proportion of Small, Dense Low-Density Lipoprotein Particles and Lower Adiponectin Blood Levels Predict Early Structural Valve Degeneration of Bioprostheses
170. Hypertriglyceridemic waist: missing piece of the global cardiovascular risk assessment puzzle?
171. Angiotensin receptor blockers are associated with a lower remodelling score of stenotic aortic valves
172. Treatment of lipid disorders in obesity
173. Effect of rimonabant on carotid intima–media thickness (CIMT) progression in patients with abdominal obesity and metabolic syndrome: the AUDITOR Trial
174. Contributions of Cardiorespiratory Fitness and Visceral Adiposity to Six-Year Changes in Cardiometabolic Risk Markers in Apparently Healthy Men and Women
175. Inflammatory biomarkers, physical activity, waist circumference, and risk of future coronary heart disease in healthy men and women
176. 50 - Obesity and Cardiometabolic Disease
177. Visceral adiposity and liver fat as mediators of the association between cardiorespiratory fitness and plasma glucose-insulin homeostasis
178. Circulating IGFBP-2 levels reveal atherogenic metabolic risk in schizophrenic patients using atypical antipsychotics
179. ApoCIII-Lp(a) complexes in conjunction with Lp(a)-OxPL predict rapid progression of aortic stenosis
180. Lipid assessment, metabolic syndrome and coronary heart disease risk
181. Sugar-Sweetened Beverages and Risk of Metabolic Syndrome and Type 2 Diabetes: A meta-analysis
182. Authorsʼ reply: Disease prevention and sedentary lifestyle
183. Risk Factors for Adult Overweight and Obesity: The Importance of Looking Beyond the ‘Big Two’
184. The hypertriglyceridemic-waist phenotype and the risk of coronary artery disease: results from the EPIC-Norfolk Prospective Population Study
185. Disease prevention—should we target obesity or sedentary lifestyle?
186. Predicting longevity using metabolomics: a novel tool for precision lifestyle medicine?
187. Plasma soluble tumour necrosis factor-α receptor 2 is elevated in obesity: specific contribution of visceral adiposity
188. Does abdominal obesity have a similar impact on cardiovascular disease and diabetes? A study of 91 246 ambulant patients in 27 European Countries
189. CB1 antagonists for obesity—what lessons have we learned from rimonabant?
190. Associations of the Limb Fat to Trunk Fat Ratio With Markers of Cardiometabolic Risk in Elderly Men and Women
191. Targeting abdominal obesity and the metabolic syndrome to manage cardiovascular disease risk: Cardiovascular disease prevention
192. Middle-aged men with increased waist circumference and elevated C-reactive protein level are at higher risk for postoperative atrial fibrillation following coronary artery bypass grafting surgery
193. High-Density Lipoprotein Particle Size and Concentration and Coronary Risk
194. Comparison of prognosis for men with type 2 diabetes mellitus and men with cardiovascular disease
195. The Quest for the Optimal Assessment of Global Cardiovascular Risk: Are Traditional Risk Factors and Metabolic Syndrome Partners in Crime?
196. Contribution of age and declining androgen levels to features of the metabolic syndrome in men
197. Evidence of QTLs on chromosomes 13q and 14q for triglycerides before and after 20 weeks of exercise training: The HERITAGE Family Study
198. Inflammatory markers and long-term risk of ischemic heart disease in men: A 13-year follow-up of the Quebec Cardiovascular Study
199. Detection of a major gene effect for LDL peak particle diameter and association with apolipoprotein H gene haplotype
200. Visceral Obesity and Plasma Glucose-Insulin Homeostasis: Contributions of Interleukin-6 and Tumor Necrosis Factor-α in Men
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.